23 Jul, 2026
According to Straits Research the global protein expression market was valued at $1613.04 million in 2025 and is anticipated to grow from $1775.96 million in 2026 to $3834.7 million by 2034, registering a CAGR of 10.1% during the forecast period 2026–2034.Protein expression refers to the biotechnological process of producing specific proteins. By manipulating gene expression in organisms of interest, these proteins are made. The procedure causes organisms to express enormous quantities of recombinant genes. Genetic engineering and recombinant technologies have created numerous opportunities for expressing and isolating heterologous proteins for scientific, industrial, and clinical applications. In addition, significant advances in biotechnology have enabled the large-scale expression and isolation of recombinant proteins. Creating recombinant proteins with cell-accessible domains is one of the most significant achievements. The prokaryotic system using Escherichia coli was the first expression platform developed. Other expression systems, including yeast, algae, insects, and mammals, followed this evolution.
Surge in the Prevalence of Chronic Diseases Drives the Global Market
The percentage of the global disease burden caused by chronic diseases increased from 46% in 2001 to 57% in 2020. More than half of the burden of chronic disease is attributable to cardiovascular disease, while the prevalence of diabetes is alarming. In both developed and developing regions, the circumstance is identical. The demand for treatment and management of these chronic diseases is increasing due to their growing prevalence. Therapeutic applications that target significant indications, such as chronic diseases, utilize protein expression systems extensively. Therefore, the market will expand over the next few years.
Rise in Pharmaceutical Market in Emerging Regions Creates Tremendous Opportunities
The pharmaceutical industry has developed substantially in emerging economies such as India and China. According to IQVIA Holdings, Inc., the pharmaceutical industry will continue to thrive over the next five years at a rate of 5% to 6% in China and 8% to 9% in India, respectively. Expanding pharmaceutical markets offer enormous opportunities for developing novel therapies, which are anticipated to increase the use of protein expression systems, thereby contributing to the expansion of the market.
North America is the most significant global protein expression market shareholder and is anticipated to exhibit a CAGR of 10.1% over the forecast period. This is primarily due to the increasing elderly population in North America and chronic diseases. In this region, the use of protein expression to identify affordable and accessible treatment options for chronic diseases such as cancer has increased over time. In addition, increased financing by various companies in their respective research and development sectors has contributed to the market's anticipated expansion. In addition to the presence of numerous large biopharmaceutical, biotechnology, and pharmaceutical companies in this region, such as Pfizer Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc., the rise of age-related diseases and the prevalence of chronic diseases such as cancer also contribute to the expansion of the market. Increasing protein research, expenditures also contribute to expanding the protein expression market. However, the substantial financial resources required to produce protein products inhibit the market's growth.
Europe is estimated to exhibit a CAGR of 9.6% over the forecast period. Europe rates second on the global protein expression market due to the growing use of protein expression in cancer and other disease therapies. Europe has a high cancer prevalence rate, with approximately 3.45 million newly diagnosed cases and 1.75 million cancer fatalities annually. The protein expression market in Europe is bolstered by an increase in disposable income and the accessibility of a database of protein structures. Additionally, as the elderly population is more likely to develop chronic diseases, other variables, such as the increase in the elderly population, support the market growth in the region. The presence of significant contract research firms that facilitate research on protein expression and the subsequent production of vaccines and antibodies also contributes to expanding the market. In addition, the high prevalence of diabetes in this region is expected to contribute to market growth through increased demand for biologics.
sales@straitsresearch.com